Akero Therapeutics(AKRO.US)

Last Updated 19:00:00 ET
longbridge loading

22:54 ETCadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026

prnewswire·
US
AKRO
0.00%
US
XBI
-0.88%
US
BBH
-0.44%
prnewswire·
US
AKRO
0.00%
US
XBI
-0.88%
US
BBH
-0.44%

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire·
US
ULY
0.00%
US
EQH
-0.35%
US
CRBG
-0.33%
prnewswire·
US
ULY
0.00%
US
EQH
-0.35%
US
CRBG
-0.33%

23:28 ETAkeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L) 1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026

prnewswire·
US
BIS
0.00%
US
LABU
-2.66%
US
BIB
0.00%
prnewswire·
US
BIS
0.00%
US
LABU
-2.66%
US
BIB
0.00%

05:40 ETIvonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026

prnewswire·
US
SBIO
+0.04%
US
VHT
-0.55%
US
BBH
-0.44%
prnewswire·
US
SBIO
+0.04%
US
VHT
-0.55%
US
BBH
-0.44%

22:05 ETAkeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance

prnewswire·
US
FBT
-0.72%
US
XBI
-0.88%
US
BIB
0.00%
prnewswire·
US
FBT
-0.72%
US
XBI
-0.88%
US
BIB
0.00%

Aker BioMarine Registers Share Capital Increase from Employee Share Program

Tip Ranks·
US
BBH
-0.44%
US
ARKG
-1.30%
US
IBB
-0.73%
Tip Ranks·
US
BBH
-0.44%
US
ARKG
-1.30%
US
IBB
-0.73%

21:59 ETACROBiosystems fördert Innovationen bei JPM Spotlight-Sessions von bioSeedin und unterstützt strategisch den Aufbau globaler Partnerschaften

prnewswire·
US
BIB
0.00%
US
ARKG
-1.30%
US
SBIO
+0.04%
prnewswire·
US
BIB
0.00%
US
ARKG
-1.30%
US
SBIO
+0.04%

Agomab Announces Launch of Initial Public Offering

fidelity·
US
APGE
+0.32%
US
NLSP
0.00%
US
SBIO
+0.04%
fidelity·
US
APGE
+0.32%
US
NLSP
0.00%
US
SBIO
+0.04%
© 2026 Longbridge｜Disclaimer